Resilio Pharmaceuticals Private Limited

Resilio Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74999TG2018PTC125588 Incorporated 11 July 2018 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹62.1 Lakh
▲ 10% YoY
Net profit · FY 2024
₹2.24 Lakh
Net margin 3.6%
EBITDA · FY 2024
₹4.58 Lakh
EBITDA margin 7.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Resilio Pharmaceuticals Private Limited

Data last updated:

Resilio Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 July 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC125588. Its GSTIN is 36AAJCR0420M1ZC (Telangana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Khaja Rahmath Ali and Sudheer Kumar Bashetty.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – 5 – 26/2/1 Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500060.

As per the financials filed for FY 2024, the company reported a revenue of ₹62.1 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.24 Lakh (net margin 3.6%) and EBITDA of ₹4.58 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 27% over five years.

Resilio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0063383).

Company details

CIN U74999TG2018PTC125588
Registration Number 125588
Incorporation Date 11 July 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0063383

Recognitions & Rankings of Resilio Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0063383

Contact details

Resilio Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    1 – 5 – 26/2/1 Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500060
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Resilio Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Resilio Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Resilio Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Resilio Pharmaceuticals Private Limited, buy the company report.

Financials of Resilio Pharmaceuticals Private Limited

FY 2025 filings available

Resilio Pharmaceuticals Private Limited reported revenue of ₹62.1 Lakh (up 10% YoY) for FY 2024.

Revenue · FY 2024
₹62.1 Lakh ▲ 10%
Net profit · FY 2024
₹2.24 Lakh margin 3.6%
EBITDA · FY 2024
₹4.58 Lakh margin 7.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 9%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 39%
5 years · compounded
▲ 20%

Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 10% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.58 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.24 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin7.4%
Net Profit Margin3.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Resilio Pharmaceuticals Private Limited, buy the company report.

Board of directors of Resilio Pharmaceuticals Private Limited

Resilio Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Khaja Rahmath AliDirector11 Jul 20188 Years 4 MonthsCurrent
Sudheer Kumar BashettyDirector11 Jul 20188 Years 4 MonthsCurrent

Peer comparison

Resilio Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aaiva Life Care Private Limited₹62.21 Lakh (FY 2025)19.0%Delhi, India
Mezon Pharmaceuticals Private Limited₹62.12 Lakh (FY 2024)-16.0%Ludhiana, Punjab, India
Kaansla Pharmaceuticals Private Limited₹62.11 Lakh (FY 2025)58.0%Panchkula, Haryana, India
Resilio Pharmaceuticals Private Limitedthis company₹62.1 Lakh (FY 2024)₹2.24 Lakh3.6%10.0%Hyderabad, Telangana, India
Meracus Pharmaceuticals Private Limited₹62 Lakh (FY 2024)31.0%Kolkata, West Bengal, India
Avinatural Herbal Private Limited₹61.93 Lakh (FY 2024)-25.0%Delhi, India

To see the full peer comparison of Resilio Pharmaceuticals Private Limited, buy the company report.

Auditor

Resilio Pharmaceuticals Private Limited is audited by RAJU SINGHVI & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
RAJU SINGHVI & COFY 2020015432S

Shareholding

The shareholding of Resilio Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Resilio Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Resilio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Resilio Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAJCR0420M1ZCTelanganaActive30 Jul 2018

To see the full GST registrations and return filing status of Resilio Pharmaceuticals Private Limited, buy the company report.

Recent activity

Resilio Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Khaja Rahmath Ali was appointed as Director on 11 Jul 2018.

AGM
Resilio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Resilio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Khaja Rahmath Ali was appointed as Director.
Appointed
Sudheer Kumar Bashetty was appointed as Director.
Incorporation
11 Jul 2018
Resilio Pharmaceuticals Private Limited was registered on 11 Jul 2018 with Roc Hyderabad & aged 8 years 4 months as per MCA records.

Frequently asked questions

Resilio Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 July 2018 (8+ years old) and is registered under CIN U74999TG2018PTC125588.

Resilio Pharmaceuticals has 2 current directors:

The latest financial statements of Resilio Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Resilio Pharmaceuticals is 36AAJCR0420M1ZC, registered in Telangana.

The CIN (Corporate Identification Number) of Resilio Pharmaceuticals is U74999TG2018PTC125588. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Resilio Pharmaceuticals was incorporated on 11 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Resilio Pharmaceuticals by revenue are Aaiva Life Care Private Limited, Mezon Pharmaceuticals Private Limited, Kaansla Pharmaceuticals Private Limited, Meracus Pharmaceuticals Private Limited, Avinatural Herbal Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Khaja Rahmath Ali was appointed as Director on 11 Jul 2018. Sudheer Kumar Bashetty was appointed as Director on 11 Jul 2018.

Yes, Resilio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0063383).

The registered office of Resilio Pharmaceuticals is at 1 – 5 – 2621 Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500060.

Resilio Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.